Checkout {{itemincart}}

The Well Bioscience

New Distribution Agreement

we are pleased to announce a new agreement for the distribution of The Well Bioscience products.

TheWell Bioscience Inc., a New Jersey biotech company focused on 3D cell culture, launched VitroINK™, a new series of xeno-free tunable bioink system that requires no UV, no temperature/pH curing or chemical crosslinking in 2020.

3D bioprinting is an emerging technology to construct complex and physiologically relevant multicellular tissue or disease models for regenerative medicine and drug discovery. Despite its significant potential, there are tremendous challenges in cytocompatibility, printability, and adjustable mechanical properties of current bioinks for 3D scaffold fabrication and long-term cell culture. Also, the crossing methods of current bioinks rely on temperature adjustment, chemical reactions, or UV curing, which would cause cell damage during the process. 

TheWell Bioscience Inc.’s mission is to accelerate the process of drug discovery and personalized medicine. “Our goal is to fill the gap between 2D studies and animal models with a robust 3D model analysis platform to achieve better efficiency and empower life science research,” said John Huang, CEO and founder of TheWell Bioscience.  

for more information visit the website www.thewellbio.com

back